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Abstract
Background: Effective treatment of chronic fatigue syndrome (CFS) with cognitive behavioural
therapy (CBT) relies on a correct classification of so called 'fluctuating active' versus 'passive'
patients. For successful treatment with CBT is it especially important to recognise the passive
patients and give them a tailored treatment protocol. In the present study it was evaluated whether
CFS patient's physical activity pattern can be assessed most accurately with the 'Activity Pattern
Interview' (API), the International Physical Activity Questionnaire (IPAQ) or the CFS-Activity
Questionnaire (CFS-AQ).
Methods: The three instruments were validated compared to actometers. Actometers are until
now the best and most objective instrument to measure physical activity, but they are too
expensive and time consuming for most clinical practice settings. In total 226 CFS patients enrolled
for CBT therapy answered the API at intake and filled in the two questionnaires. Directly after
intake they wore the actometer for two weeks. Based on receiver operating characteristic (ROC)
curves the validity of the three methods were assessed and compared.
Results: Both the API and the two questionnaires had an acceptable validity (0.64 to 0.71). None
of the three instruments was significantly better than the others. The proportion of false
predictions was rather high for all three instrument. The IPAQ had the highest proportion of
correct passive predictions (sensitivity 70.1%).
Conclusion: The validity of all three instruments appeared to be fair, and all showed rather high
proportions of false classifications. Hence in fact none of the tested instruments could really be
called satisfactory. Because the IPAQ showed to be the best in correctly predicting 'passive' CFS
patients, which is most essentially related to treatment results, it was concluded that the IPAQ is
the preferable alternative for an actometer when treating CFS patients in clinical practice.
Introduction
Chronic fatigue syndrome (CFS) is characterized by unex-
plained severe fatigue that does not resolve with bed rest,
lasts for at least six months and causes serious reductions
in daily functioning [1]. Spontaneous recovery rates are
low [2,3]. Reviews of randomized controlled trials (RCTs)
have shown that cognitive behavior therapy (CBT) is the
most effective treatment for CFS [4-6]. In one of the RCTs
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included in these reviews it was found that CFS patients'
individual level of daily physical activity predicted the
CBT treatment outcome (Prins et al., 2001) [7]. Based on
their daily activity level, CFS patients can be divided into
two subgroups, distinguishing 'fluctuating active' from
'passive' CFS patients in a proportion of 75% versus 25%
respectively [8]. Fluctuating active patients generally show
infrequent bursts of activity followed by extreme exhaus-
tion, whereas passive patients usually avoid activities as
much as possible. In the trial of Prins et al. [7] it turned
out that passive CFS patients showed almost no improve-
ment. It was suggested that these passive patients might
need a different type of treatment. Therefore a more
appropriate protocol was developed [9] and tested [10]. It
is especially important that passive patients are being rec-
ognized correctly, as they do not recover when they
receive the protocol for active patients [7,11]. When active
patients accidentally receive the passive protocol, the con-
sequences are less problematic. They start complaining
quickly of exhaustion when increasing their already fluc-
tuating activity pattern; this protest alerts the therapists
and enables them to adjust the protocol so that recovery
can still be reached.
One of the major innovations of the new protocol is that
whereas fluctuating active patients start with practicing a
base line activity level that prevents bursts of activity, pas-
sive patients start directly with increasing physical activity
[11,12]. The adapted protocol has proven to be as effec-
tive for passive CFS patients as the original protocol is for
pervasively active CFS patients [10]. Therefore it is now
being used in clinical practice for passive CFS patients.
Now in order to decide which protocol should be used, it
is necessary to assess the patient's physical activity pattern.
An accurate and objective method to do this is using an
actometer. Actometers are based on an electric sensor and
yield highly reliable data [8,13,14]. But for clinical set-
tings actometers are not feasible because of a lack of per-
sonnel to instruct patients how to wear the actometer and
to read out the computerized graphics. Besides, actome-
ters can be rather expensive. An alternative method is the
short 'Activity Pattern Interview' (API) of daily activities
[9,12]. Talking through a typical day by asking concrete
questions about activities 'from minute to minute' should
deliver the needed information. Although this method is
now being used in several settings and is also included in
trainings of CBT for CFS, its validity has never been tested.
Another possibility is using self-report questionnaires.
Since the outcome of such a questionnaire is not depend-
ent on the therapist's skills, the validity of such a question-
naire might be higher and more stable than that of an
interview. Several 'physical activity questionnaires' are
available for this purpose [15-18]. In this study the widely
used and validated International Physical Activity Ques-
tionnaire (IPAQ) [18], and a newly developed CFS Activ-
ity Questionnaire (CFS-AQ) were evaluated. We
developed the CFS-AQ because it was presumed that the
IPAQ, as other existing activity questionnaires designed
for the general population, might not suit the typical low
activity levels of CFS patients.
The present study evaluates and validates these three alter-
native methods to assess CFS patients activity pattern. The
research questions of the present study are: 1. What is the
validity and sensitivity of the API when assessing CFS
patients' activity pattern? 2. Do the IPAQ and the CFS-AQ
assess activity pattern better than the API? The hypothesis
was that the CFS-AQ would show a higher validity than
the IPAQ and the API.
Methods
Subjects and procedure
In this study 226 consecutive CFS-patients aged between
16 and 65 participated. They were all referred between
January 2004 and October 2005 by a medical specialist or
general practitioner to the Nijmegen Expert Centre for
Chronic Fatigue (ECCF). All participants fulfilled the
CDC-94 criteria for CFS [1]. The main complaint of severe
fatigue was indicated by scores of 35 or higher on the
Checklist Individual Strength (CIS) subscale 'fatigue
severity' [19]. Severe impairment was defined by a cut off
score of 700 or higher on the Sickness Impact Profile (SIP)
[20]. Data for this study were obtained during the patients
first two visits to the centre. During the intake session the
six therapists participating in this study performed the
API. All therapists were trained and experienced in CBT for
CFS. Their training included assessing the activity pattern
of the patient with the API. During the second visit (diag-
nostic test session) patients completed the IPAQ and the
CFS-AQ. Additionally they got instructions to wear the
actometer for the next two weeks. Before starting this
study it was judged by the Nijmegen Medical Hospital
Ethical Commission, who indicated no need for informed
consent.
Measures
API
The API investigates the usual activities of a patient on a
typical day. It consists of a form with three relevant topics
that are questioned during the intake interview. On bases
of these topics the therapist forms a final judgement in the
form of a dichotomous outcome, namely 'passive' or
'active'. These topics are: the routine pattern of activities
and the amount of time laying or sitting during the day of
yesterday, the number of times leaving the house during a
day and practicing a paid or unpaid job or not. To investi-
gate the routine daily living pattern, the day of yesterday
is being questioned 'from minute to minute', as concrete
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as possible, like it would be registered by a camera. To
minimise a recall-bias, usually the day of yesterday is
being used, only when this was not a typical day or a
weekend day another day in the past week is being inves-
tigated.
The passive CFS patient can be recognized by spending a
great deal of time lying down, going out infrequently and
not practicing a job anymore. In most patients it takes
about ten minutes to administer the API. The therapists
were instructed to fill in this form during the intake, their
definite activity pattern judgement included.
IPAQ
The short form IPAQ is a 9-item scale, providing informa-
tion on the amount of minutes spent in vigorous and
moderate intense activity and walking during the last 7
days, for which separate sub scale scores can be calculated,
for work-related, transportation, housework/gardening
and leisure-time activity. Filling in the IPAQ takes about
5–7 minutes. The IPAQ has a good test-retest reliability
(Spearman's ρ = 0.80) and a moderate criterion validity
(Spearman's ρ = 0.30) with an accelerometer [18].
CFS-AQ
The activity questionnaire was developed at the ECCF. It
contains 10 items concerning questions about activities in
the last two weeks, with four sub scales: 'physical activity'
(four questions), 'rest' (four questions), 'using aids' (one
question) and 'social activity' (one question). Each item is
scored on a four point Likert scale. It takes about 5–7 min-
utes to fill in the CFS-AQ. The CFS-AQ internal consistent
reliability and test-retest reliability were tested in this
study's population and were acceptable (Cronbach's
alpha 0.73; Spearman's ρ 0.72).
Actometer
The actometer (©Actilog V3.0) is a little box (43*29*16
mm) that has a piëzo-electric sensor, which is sensitive in
three directions. It is worn on the ankle, usually for 14
days in order to retain 12 complete registration days. Sen-
sor acceleration results in an output signal, all signals
above a certain threshold are added to a pulse generator.
This pulse generator triggers a 2-bit counter that adds the
registered value to an 'integration counter' every five min-
utes [13], from which mean Daily Physical Activity scores
are computed. Actometers yield valid and highly reliable
data in the healthy population [13] and in the CFS popu-
lation [8,14].
The activity pattern of passive CFS patients is defined by
scoring zero or one of the 12 days above a CFS reference
score. This reference score is the mean Daily Physical
Activity score of CFS patients. Fluctuating active CFS
patients score two or more of the 12 days above this CFS
reference score and mostly present an irregular, 'fluctuat-
ing' graphic.
Analyses
First, correlations between the three instruments and the
continuous actometer scores were analyzed. After that
logistic regression analyses were performed with the IPAQ
and the CFS-AQ, using actometer typology as dependent
variable, to gain their predicted probability scores and a
dichotomous outcome scale of activity level. From the
regression analysis results we obtained the parameters for
the CFS-AQ and the IPAQ that are needed to prescribe a
formula that can predict a patients' activity pattern accord-
ing to the actometer. The formula for the CFS-AQ predict-
ing the probability that a particular patient is active
became:
('physical' = score on subscale 'physical activity', 'rest'=
score on subscale 'rest', 'aids' = score on subscale 'using
aids', and 'social' = score on subscale 'social activities').
And the formula for the IPAQ predicting the probability
that a particular patient is active became:
('walking'= score on subscale 'walking', 'moderate'= score
on subscale 'moderate activities', 'heavy'= score on sub-
scale 'heavy activities'). The API did not need such analy-
sis, since it resulted in a dichotomous outcome directly.
With the predicted probability scores derived from the
regression analysis, receiver operating characteristic
(ROC) curves were constructed for all three instruments in
order to analyze sensitivity and specificity levels (figure
1). 'Sensitivity' represented the proportion of passive
patients correctly classified as passive, whereas 'specificity'
was defined as the proportion of active patients correctly
classified as active. A ROC curve shows the trade-off
between sensitivity and specificity for all possible pre-
dicted values. The ROC area under the curve represents
the validity of a model. The higher the curve and the more
it follows the vertical axis, the more accurate the model
[21]. An area of 1 represents a perfect validity whereas an
area of 0,5 would be identical to just guessing. A rough
guide for classifying the accuracy of a diagnostic test is the
traditional academic point system: .90–1 = excellent, .80–
.90 = good, .70–.80 = fair, .60–.70 = poor, .50–.60 = fail.
For each curve, at one 'cut off' point the combination of
sensitivity and specificity is optimal [21]. The best cut off
points for the IPAQ and the CFS-AQ were determined by
calculating and computing sensitivity and specificity at
p active
e physical rest aid
( )
( . . * . * . *
=
+ − − + + +
1
1 3 667 0 243 0 088 0 418 s social−0 192. * )
p active
e physical rest aid
( )
( . . * . * . *
=
+ − − + + +
1
1 3 667 0 243 0 088 0 418 s social−0 192. * )
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different cut off points and find the point with the highest
score. Cross tabulations were constructed to support com-
parison of the three methods. Finally it was investigated
whether the areas under ROC curves were significantly dif-
ferent by calculating a Z score using the formula of Hanley
& Mc Neil [22]. All statistical analyses were conducted
using SPSS version 12.01.
Results
Descriptives and demographics
The mean age of participating patients was 37 years (SD
11.3 range 15–68). The male/female ratio was 26%/74%
(59 male, 167 female), median duration of fatigue was 5
years (range 2–32). According to the actometer measures,
29% of the patient population had a passive activity pat-
tern and 71% had a fluctuating active one.
Validity of the instruments
The correlation of the API and the IPAQ with the actome-
ter scores appeared to be weak (Spearman's ρ = 0.27 and
ρ = 0.33 respectively). The CFS-AQ showed a moderate
correlation with the actometer (Spearman's ρ = 0.41).
Figure 1 and table 1 show the area under the curve (repre-
senting the validity) for the CFS-AQ, the IPAQ and the
API. As can be seen, the validity of the API (0.643) was
somewhat smaller than that of the two questionnaires
(0.710 and 0.711). Following the method of Hanley and
Mc Neil [22], the validity of the three instruments was not
significantly different however [see additional file 1].
Sensitivity of the instruments
Based on the API, 52.3% of all passive CFS patients were
correctly classified as passive (sensitivity) and 75.8% of all
active patients were correctly classified as fluctuating
active (specificity) (table 2). The optimum predicted
probability cut off for the CFS-AQ was at 0.73, by which a
sensitivity of 64.6% was reached combined with a specif-
icity of 65.2% (table 3). For the IPAQ the best predicted
probability cut off was at 0.67 with a sensitivity of 70.1%
and a specificity of 62.7% (table 4).
Receiver operating characteristic (ROC) curves of the IPAQ, CFS-AQ and API predicting CFS-patients daily activity typology, b st cut-off points of CFS-AQ and IPAQ marked with (black circle)Figure 1
Receiver operating characteristic (ROC) curves of the IPAQ, CFS-AQ and API predicting CFS-patients daily 
activity typology, best cut-off points of CFS-AQ and IPAQ marked with (black circle).
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For scoring the IPAQ and the CFS-AQ, the formula's given
in this article have to be filled in the following way: the
scores on the different subscales of a particular patient
have to be filled in at the corresponding place in the for-
mula. Afterwards the formula has to be calculated, which
can best be done by using a program like Excel. Finally
one should check whether the outcome of this calculation
lies above or below the cut off point of 0.73 (when scoring
the CFS-AQ) or 0.67 (when scoring the IPAQ).
Discussion
This study investigated whether the structured 'Activity
Pattern Interview' (API), the International Physical Activ-
ity Questionnaire (IPAQ) and the CFS-Activity Question-
naire could accurately assess the daily activity pattern of
CFS patients.
It appeared that all three instruments had a fair validity
and none of the instrument was significantly better than
the others. Contrary to our hypothesis, the CFS-AQ, a
questionnaire specifically developed for CFS, was not
more accurate than the IPAQ or the API. This implies in
the first place that the design of a questionnaire especially
for CFS patients did not result in a significantly higher
validity than the already existing IPAQ. Secondly, these
results show that some training and experience in per-
forming the API interview are apparently enough to
almost equal a questionnaire. A third implication, of the
finding that all three instruments showed a fair validity, is
that the three tested instruments could all be used to pre-
dict activity pattern in CFS patients, but that the rather
high proportion of false predictions remains a serious
problem that needs attention in future studies.
A practical question that remains is: what should be
advised for therapists in clinical practice? Which of the
three instruments could best be used if no actometers are
available? Although the validity of the three instruments
appeared to be fair, and hence in fact none of the instru-
ments can really be called satisfactory, the percentage of
correctly classified passive patients (sensitivity) was the
highest for the IPAQ (namely 70.1%, table 4). Given the
fact that especially the unjust classification of passive
patients as active should be minimized, since they do not
recover with the protocol for active patients [11], we
advise that the IPAQ is now the best available alternative
for an actometer.
An advantage of the IPAQ is that its original scoring pro-
tocol provides a categorical outcome of three activity lev-
els (low, moderate and high) and even a continuous score
(calculating MET per minutes). Although these algorithms
are not useful for the purpose of classification these out-
comes might provide useful information for counseling
sessions or follow-up information.
From a more practical perspective one could argue to use
the API instead of the IPAQ, since it has a direct dichoto-
mous outcome and hence does not need the use of com-
plicated formulas. However, since adequate use of the API
asks for therapists who are experienced with CFS and
trained in using the interview, this advise should not be
given to therapists without such experience.
A strong point of this study is the fact that it concerns a
clinically relevant question with important treatment con-
sequences. A methodological limitation of this study is
the fact that the predicted models of the questionnaires
were derived from the same population as in which after-
Table 1: Area under the ROC curve of the API, CFS-AQ and the IPAQ
Test Results Variables Area Under the Curve Std. Error Asymptotic significance b Asymptotic 95% confidence Interval
Lower bound Upper bound
Activity Pattern Interview 0.643 0.042 0.001 0.562 0.725
CFS Activity Questionnaire 0.710 0.036 0.000 0.640 0.781
IPAQ 0.711 0.039 0.000 0.634 0.788
Table 2: Sensitivity and specificity of the Activity Pattern Interview (N = 226)
Actometer typology
Passive Active
Activity Pattern Interview Passive (N/%) 34/(52.3%) (= sensitivity) 39/(24.2%) 73 (32%)
Active (N/%) 31/(47.7%) 122/(75.8%) (= specificity) 153 (68%)
65/(100%) 161/(100%) 226 (100%)
Predictive value of a positive test (sensitivity) PV+ = 34/65 = 0.523
Predictive value of a negative test (specificity) PV- = 122/161 = 0.758
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wards the ROC curves were constructed. This implies that,
when tested in a possible validation study, the instru-
ments might show a somewhat lower validity, although
probable still better than 'just guessing'.
Compared to other studies, the correlations of the three
tested instruments with objective measurements are not
different from other established self-report physical activ-
ity questionnaires. None of the regularly used physical
activity questionnaires that have been validated against
objective measurements, e.g. the SQUASH [18] the LASA
[17] or the Baecke questionnaires [16] have shown corre-
lations above 0.45. A review that summarized reliability
and criterion validity for seven questionnaires, reported a
median validity correlation of about 0.3 [23]. All self
report measurements of physical activity seem to suffer
from the inherent problem that people are not able to
report this kind of behavioral aspects correctly. Besides
that, accidental activity peaks or rest periods might influ-
ence actometers more than questionnaire results, which
might also limit correlations. Probably more benefits can
be gained with a daily registration by the patient of phys-
ical activity. Another option could be to include the opin-
ion of a direct partner of the patients in the reporting of
daily activities.
Conclusion
To conclude, the results of this study suggest that mearus-
ing physical activity pattern in CFS patients with self-
report measurements remains a difficult matter. The con-
tributions of this study are in the first place the finding
that a specific 'CFS activity questionnaire' does not result
in higher validity than that of already existing question-
naires. Secondly, this study makes clear that the validity of
an 'Activity Pattern Interview' for CFS patients is not
directly better than that of self report questionnaires.
For the clinical practice of CFS treatments, this study's
results indicate that, when actometers are not available,
the IPAQ is the preferred alternative instrument to use,
because of its somewhat lower level of unjust passive clas-
sifications.
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